BRIEF published on 10/22/2024 at 14:59, 2 years ago Position du groupe Vanguard sur Hargreaves Lansdown Participations Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Hargreaves Lansdown
BRIEF published on 10/22/2024 at 14:58, 2 years ago The Vanguard Group Discloses 5.47% Stake in Britvic Plc Securities Disclosure Britvic Plc Vanguard Group Shareholding
BRIEF published on 10/22/2024 at 14:58, 2 years ago Le groupe Vanguard révèle une participation de 5,47 % dans Britvic Plc Britvic Plc Actionnariat Titres Groupe Vanguard Divulgation
BRIEF published on 10/22/2024 at 14:56, 2 years ago The Vanguard Group Discloses Position in Smith (DS) plc Takeover Code Vanguard Group Smith (DS) Plc Securities Transactions Shareholding Disclosure
BRIEF published on 10/22/2024 at 14:56, 2 years ago Le groupe Vanguard révèle sa position dans Smith (DS) plc Smith (DS) Plc Groupe Vanguard Code De Prise De Contrôle Déclaration De Participation Opérations Sur Titres
BRIEF published on 10/22/2024 at 14:55, 2 years ago Vanguard Discloses Position in Spirent Communications Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Spirent Communications
BRIEF published on 10/22/2024 at 14:55, 2 years ago Vanguard dévoile sa position dans Spirent Communications Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Spirent Communications Divulgation Des Actions
BRIEF published on 10/22/2024 at 14:50, 2 years ago Pernod Ricard Reports Q1 FY25 Sales Decline, Impacted by Challenges in China and USA Organic Growth Market Performance Q1 FY25 Sales China & US Markets Foreign Exchange Impact
BRIEF published on 10/22/2024 at 14:50, 2 years ago Pernod Ricard annonce une baisse de ses ventes au premier trimestre de l'exercice 2025, impactée par les difficultés rencontrées en Chine et aux États-Unis Croissance Organique Performance Du Marché Ventes Du Premier Trimestre De L'exercice 25 Marchés Chinois Et Américains Impact Des Taux De Change
BRIEF published on 10/22/2024 at 14:50, 2 years ago Xenetic Biosciences' Abstract Accepted for Presentation at SITC 2024 Xenetic Biosciences Cancer Treatment Immuno-oncology DNase Platform SITC 2024
Published on 11/13/2026 at 18:30, 1 hour 47 minutes ago Sparta Capital Ltd. Announces Application to the Ontario Securities Commission to Become a Reporting Issuer in Ontario
Published on 11/13/2026 at 18:05, 2 hours 12 minutes ago Integrated BioPharma Reports Results for its Quarter Ended September 30, 2026
Published on 11/13/2026 at 17:25, 2 hours 52 minutes ago Sekur Private Data Raises SekurOne Price 25% to US$3,750 Per Year
Published on 11/13/2026 at 15:40, 4 hours 37 minutes ago Vulcan Minerals Inc. - Review and Update on Affiliated Company Atlas Salt Inc.
Published on 11/13/2026 at 15:30, 4 hours 47 minutes ago Road Access Completed Drill Program to Begin
Published on 11/13/2026 at 19:08, 1 hour 9 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 hour 17 minutes ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 18:04, 2 hours 13 minutes ago EQS-Adhoc: CHAPTERS Group AG: Capital Increase from Authorized Capital Resolved
Published on 11/13/2026 at 11:35, 8 hours 42 minutes ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 8 hours 42 minutes ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 12 hours 17 minutes ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 21 hours 4 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
